4-epi-vancosaminyl derivative of vancomycin

Star0

DB04431ExperimentalSmall molecule

4-epi-vancosaminyl derivative of vancomycin: Overview.

Formula / weight: C₇₃H₉₁Cl₂N₁₀O₂₆ · 1595.47 g/mol (avg)

Resolves to

Compound

PubChem131704282

Structure

InChIKeyXJHXLMVKYIVZTE-LOALFDMRSA-QSMILES

[H]N([H])C(=O)C[C@@H]1N([H])C(=O)[C@H](N([H])C(=O)[C@@H](CC(C)C)[N+]([H])([H])C)[C@H](O)C2=CC(Cl)=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@@](C)([C@@H](O)[C@H](C)O4)[N+]([H])([H])[H])C4=CC(=C3)[C@@]([H])(N([H])C1=O)C(=O)N([H])[C@]1([H])C3=CC(=C(O)C=C3)C3=C(C=C(O)C=C3O)[C@H](N([H])C(=O)[C@@]([H])(N([H])C1=O)[C@H](O[C@H]1C[C@@](C)([C@@H](O)[C@H](C)O1)[N+]([H])([H])[H])C1=CC(Cl)=C(O4)C=C1)C(O)=O)C=C2

Which companies are running trials of 4-epi-vancosaminyl derivative of vancomycin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account